Skip to Content

Glossary

Starting with A for "ACE inhibitor" and continuing through to Y for "Yolk Sac Tumour", we give you succinct explanations for scientific and medical terms in clear and simple words.




A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Prostate carcinoma
Malignant tumour of the prostate. Prostate carcinoma is the most frequent malignant tumour in man and mostly occurs between 50 and 70 years of age. It initially spreads within the prostate and then grows into the seminal vesicles, the connective tissue of the pelvis and (more rarely) into the bladder, the colon and the urethra. Metastases arise when the tumour cells are spread through the lymph ducts and blood into the pelvic area, skeleton, liver or lungs. Some cases of prostate carcinoma are so-called latent prostate carcinoma, which never cause symptoms and which do not primarily cause death. The patients usually die of other causes and the carcinoma is only found by chance during the autopsy.

Symptoms: Problems in emptying the bladder, pain when passing urine, blood in the urine and back pains (like sciatica) only develop when the disease is advanced.

Diagnosis: Rectal investigation and palpation of the prostate through the intestine (part of the cancer screening tests). If the findings on palpation are abnormal, prostate cells can be extracted through the intestine with a thin needle and then examined under the microscope. Ultrasound investigations and clinical chemistry tests are also performed. To look for metastases, X-rays of the skeleton, computer tomography and nuclear spin tomography can be performed, possibly also including taking a sample of lymph nodes from the pelvis.

Therapy: Depending on the type of the tumour, operative removal of the prostate together with the neighbouring lymph nodes, radiotherapy and reduction of the male sex hormone which can further tumour growth, by removing the testicles of administering blocking drugs. Therapy can be dispensed with if the patient is very old or the tumour of low malignancy.

Prognosis: 90% of cases are cured if the therapy is started at an early stage.

Glossary entries:  Roche and Walter de Gruyter, Berlin